Body Screening for Melanoma Detection

Melanoma represents 5% of skin cancer cases, but causes 75% of deaths. Early detection reduces risk of hospitalizations, complications and death

At Dermaderm we have vexia photofinder equipment, it is a device that has computer-assisted algorithms and Artificial Intelligence (AI) to analyze and track moles; This combined with the clinical assessment of Dr. Itzel Martinez, dermatologist expert in skin cancer and dermoscopy.

Who should undergo this study?

• Personal history of melanoma
• Family history of melanoma
• Dysplastic nevus syndrome (more than 100 moles, more than 6 dysplastic)
• Present the CDKN2A or CDK4 mutation

What does the study consist of?

Our staff will take photos of the entire body and subsequent dermatoscopy photos (magnification up to 100x) of melanocytic nevus type lesions (moles) selected by the dermatologist. An artificial intelligence program will be used in these, as well as the application of dermoscopic criteria. , to evaluate the risk of each injury. The dermatologist on our staff will issue some final recommendations such as surveillance or biopsy; If the second is required, it will be scheduled at a second time.

Lesions suspicious for other skin cancers such as basal cell carcinoma, squamous cell carcinoma, and premalignant lesions such as actinic keratosis will also be evaluated.

At the end of the study you will be given a report, we recommend you come with a USB or it can be sent by email

Please note that the evaluation can last from one to three hours, please ask for your patience.

What is the cost?

• Full body evaluation and analysis of <10 moles by AI $3500
• Full body evaluation and analysis of >10 moles by AI $4500
• Does not include biopsies, cryosurgery or other extra treatment
• The cost of a single and timely evaluation with our system is $400 per injury plus the consultation.

If you have more questions, do not hesitate to ask them at the reception of the 200 MAC hospital office or call 415 197 22 08 or quotes@dermaderm.mx